BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28877383)

  • 1. Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis.
    Heldt S; Eigl S; Prattes J; Flick H; Rabensteiner J; Prüller F; Niedrist T; Neumeister P; Wölfler A; Strohmaier H; Krause R; Hoenigl M
    Mycoses; 2017 Dec; 60(12):818-825. PubMed ID: 28877383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples.
    Heldt S; Prattes J; Eigl S; Spiess B; Flick H; Rabensteiner J; Johnson G; Prüller F; Wölfler A; Niedrist T; Boch T; Neumeister P; Strohmaier H; Krause R; Buchheidt D; Hoenigl M
    J Infect; 2018 Sep; 77(3):235-241. PubMed ID: 29972764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis values of IL-6 and IL-8 levels in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
    Liu F; Zhang X; Du W; Du J; Chi Y; Sun B; Song Z; Shi J
    J Investig Med; 2021 Oct; 69(7):1344-1349. PubMed ID: 34127514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
    Prattes J; Lackner M; Eigl S; Reischies F; Raggam RB; Koidl C; Flick H; Wurm R; Palfner M; Wölfler A; Neumeister P; Thornton CR; Krause R; Lass-Flörl C; Hoenigl M
    Mycoses; 2015 Aug; 58(8):461-9. PubMed ID: 26103209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing Invasive Pulmonary Aspergillosis in Hematology Patients: a Retrospective Multicenter Evaluation of a Novel Lateral Flow Device.
    Mercier T; Schauwvlieghe A; de Kort E; Dunbar A; Reynders M; Guldentops E; Rijnders B; Verweij PE; Lagrou K; Maertens J
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30651395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Galactomannan Tests of Bronchoalveolar Lavage Fluid for Diagnosing Invasive Pulmonary Aspergillosis].
    Deng J; Wu SY; Liu Y; Ma Y; Xie Y; Chen ZX; Dai ZQ; Deng JL; Kang M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):124-128. PubMed ID: 29737102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.
    Zhou W; Li H; Zhang Y; Huang M; He Q; Li P; Zhang F; Shi Y; Su X
    J Clin Microbiol; 2017 Jul; 55(7):2153-2161. PubMed ID: 28446576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
    J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchoalveolar lavage fluid galactomannan detection for diagnosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
    Zhang XB; Chen GP; Lin QC; Lin X; Zhang HY; Wang JH
    Med Mycol; 2013 Oct; 51(7):688-95. PubMed ID: 23527739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of the combinations of bronchoalveolar lavage fluid galactomannan test and serum galactomannan test in invasive pulmonary aspergillosis].
    Liu L; Li J; Dong H; Jiang L; Song H; Zhang S; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Mar; 31(3):331-335. PubMed ID: 30914095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
    Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
    Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The expression of triggering receptor expressed on myeloid cells receptor-1 in Aspergillus infected mice].
    Cui N; Wang H; Su LX; Zhang JH; Liu DW
    Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):601-605. PubMed ID: 28789494
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical application of Aspergillus lateral flow device in bronchoalveolar lavage fluid of patients with classic risk factors for invasive pulmonary aspergillosis.
    Linder KA; Kauffman CA; Zhou S; Miceli MH
    Mycoses; 2019 Dec; 62(12):1189-1193. PubMed ID: 31581342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients.
    Castillo CG; Kauffman CA; Zhai J; Jiang H; Agozino SM; Miceli MH
    Mycoses; 2018 Jan; 61(1):4-10. PubMed ID: 28905439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum galactomannanan, and serum 1,3-β-d-glucan in non-neutropenic respiratory disease patients with invasive pulmonary aspergillosis.
    Dai Z; Cai M; Yao Y; Zhu J; Lin L; Fang L; Li Z; Yi H; Chen B; Liang X
    Medicine (Baltimore); 2021 Apr; 100(14):e25233. PubMed ID: 33832082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of interleukin-8 levels in the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Şensoy L; Atilla A; Güllü YT; Gür Vural D; Turgut M; Esen Ş; Tanyel E
    Med Mycol; 2024 May; 62(5):. PubMed ID: 38592958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: a prospective study in pediatric patients.
    Mohammadi S; Khalilzadeh S; Goudarzipour K; Hassanzad M; Mahdaviani A; Aarabi N; Pourabdollah M; Sigari N
    Med Mycol; 2015 Sep; 53(7):709-16. PubMed ID: 26229150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoalveolar lavage fluid and serum 1,3-β-D-glucan testing for invasive pulmonary aspergillosis diagnosis in hematological patients: the role of factors affecting assay performance.
    Weinbergerova B; Kabut T; Kocmanova I; Lengerova M; Pospisil Z; Kral Z; Mayer J
    Sci Rep; 2020 Oct; 10(1):17963. PubMed ID: 33087853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.